5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | NEUTRAL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | N/A | N/A | N/A | 44.51▼ | 43.89▲ |
MA10 | N/A | N/A | N/A | 43.30▲ | 44.97▼ |
MA20 | N/A | N/A | N/A | 44.26▲ | 43.99▲ |
MA50 | N/A | N/A | N/A | 44.38▼ | 43.12▲ |
MA100 | N/A | N/A | N/A | 45.04▼ | 39.78▲ |
MA200 | N/A | N/A | N/A | 44.22▲ | 34.25▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | N/A | N/A | N/A | 0.079▲ | -0.122▼ |
RSI | N/A | N/A | N/A | 50.155▲ | 50.539▲ |
STOCH | N/A | N/A | N/A | 65.465 | 58.004 |
WILL %R | N/A | N/A | N/A | -28.035 | -28.804 |
CCI | N/A | N/A | N/A | 33.570 | 45.887 |
Wednesday, April 30, 2025 06:57 AM
Shell (LSE:SHEL)'s recent challenges in divesting its Indian renewable platform, Sprng Energy, faced hurdles due to valuation mismatches and stalled negotiations with key players like ONGC. These ...
|
Wednesday, April 30, 2025 03:35 AM
GSK (LSE:GSK) reported a significant improvement in its first-quarter earnings, with sales, net income, and earnings per share all showing promising growth. This announcement coincided with a 5.14 ...
|
Thursday, December 12, 2024 11:48 AM
In a report released on December 11, Julien Richer from Kepler Capital maintained a Buy rating on Accor SA (0H59 – Research Report), with a price target of €47.00. The company’s shares ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/06/25 | 44.375 | 44.88 | 44.375 | 44.375 | 134 |
27/06/25 | 44.62 | 44.88 | 44.02 | 44.02 | 197 |
26/06/25 | 44.88 | 44.88 | 44.715 | 44.715 | 8,618 |
25/06/25 | 44.64 | 45.095 | 44.31 | 45.095 | 13,784 |
24/06/25 | 44.33 | 45.59 | 44.33 | 44.33 | 2 |
23/06/25 | 41.74 | 45.59 | 41.74 | 41.74 | 52 |
20/06/25 | 42.12 | 45.59 | 42.12 | 42.12 | 4 |
19/06/25 | 41.955 | 45.59 | 41.115 | 41.115 | 52 |
18/06/25 | 42.46 | 45.59 | 42.46 | 42.46 | 5 |
17/06/25 | 43.49 | 45.59 | 43.035 | 43.035 | 424 |
|
|
||||
|
|
||||
|
|